Japanese Foreign Minister Takeshi Iwaya will travel to South Korea on Monday to shore up security cooperation between the East Asian neighbours and their mutual U.S. ally that is meant to counter China's growing regional power.

North Korea tested a medium-range hypersonic ballistic missile this week which has raised concerns about Kim Jong Un's ambitious programme to further enhance his military's capabilities. On the other hand,

The top diplomats of South Korea and Japan will hold talks early next week on bilateral relations and other shared issues, Seoul's foreign ministry said Friday, The talks between Foreign Minister Cho Tae-yul and Japanese Foreign Minister Takeshi Iwaya will take place in Seoul on Monday,

Japan’s Foreign Minister Takeshi Iwaya will fly to Seoul for talks with his counterpart on Monday amid an ongoing political crisis in South Korea over short-lived martial law. Iwaya will be hosted by South Korean Foreign Minister Cho Tae-yul in what would be their first one-on-one meeting.

If the U.S. industrial base can't step up to meet the needs of American shipbuilding, perhaps South Korea and Japan can.

South Korea was experiencing the coldest day of the winter so far Thursday with temperatures ranging from 14 degrees Fahrenheit down to minus 4 degrees.

Many foreign media analyses suggest that the visit aims to solidify President Joe Biden's political legacy in terms of the US' "Indo-Pacific Strategy" and strengthen relations with Asian allies such as South Korea and Japan.

The United States, South Korea and Japan separately condemned Pyongyang's first major weapons test of the year, which will be seen as a warning directed at the administration of U.S. President ...

The government has little to show for the hundreds of billions of dollars spent on pro-natal policies over nearly two decades.

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any breaking news developments

Influenza is affecting hundreds of thousands of people in Japan and rising rapidly among that nation's population of 124.5 million and overwhelming many healthcare providers and drugmakers.